New U Life (HK) 2020 Ltd., through cooperation with direct marketing company Tianfu Tianmeishi (Xiamen) Biological Technology Co., Ltd. will sell products authorized by New U Life (HK) 2020 through a direct selling business model in specified areas within mainland China, permitted by the PRC government.
“I’m beyond thrilled to work with New U Life (HK) 2020 Ltd.,” said President of Tianfu Tianmeishi (Xiamen) Biological Technology Co., Chen Fu-Sung. “I look forward to becoming ‘TenMax New U Life’ someday. We can ride on the crest of success through our pleasant cooperation.”
The company hopes this association will strengthen New U Life (HK) 2020 Ltd.’s presence in mainland China and create new business opportunities for its members.
“Working with Tianfu Tianmeishi (Xiamen) Biological Technology Co., Ltd. is an incredible opportunity,” said Pat Berry, Vice President of International at New U Life (HK) 2020 Ltd. “We are looking forward to introducing our industry-leading products to the individuals in these regions.”
This agreement is another step in international growth for the company who introduced its product SomaDerm to Hong Kong and Taiwan, and not-for-resale in Canada, Australia and New Zealand last year.
“We are so very grateful for this cooperation with Tianfu Tianmeishi (Xiamen) Biological Technology Co., Ltd.,” said Founder of New U Life (HK) 2020 Ltd., Alexy Goldstein. “This will allow us to support our New U Life family and member base in mainland China, providing more opportunities to share our powerful products with the world.”
